MS drug approved for use in EU
A new treatment for multiple sclerosis has been approved by the European Medicines Agency, while reviewers have called for more evidence on another drug for the condition.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units